Efficacy of Intermittent Preventive Treatment of Malaria with Sulphadoxine-pyrimethamine in Preventing Anaemia in Pregnancy among Nigerian Women
Authors:
- 15 February 2008
- journal article
- research article
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 12 (6) , 692-698
Abstract
Objective To evaluate the efficacy of intermittent preventive treatment of malaria using sulphadoxine-pyrimethamine (SP) in the prevention of anaemia in women of low parity in a low socio-economic, malaria endemic setting. Method The study design was an open randomized control trial comparing anaemia incidence among pregnant women on intermittent presumptive treatment of malaria with SP with those on chloroquine (CQ). A total of 352 primigravid and secondigravid women between 16 and 30 weeks gestation receiving antenatal care at the Primary Health Care Center, Enuwa in Ile-Ife, Osun State, Nigeria were serially recruited and randomly allocated into experimental and control groups of 176 each. The experimental group received SP (to a maximum of three doses depending on the gestational age at enrollment into the study) while the control group had treatment doses of CQ at recruitment and subsequently only if they had symptoms suggestive of malaria. The primary outcome measure was anaemia (haematocrit < 30) at 34 weeks of gestation. Result At recruitment and 34 weeks gestation, there was no statistically significant difference between the experimental and control group in terms of socio-demographic characteristics and past medical history. Thirty-three (22.6%) and 52 (37.1%) women in the study and control groups, respectively, had anaemia (protective efficacy 49.5%, p = 0.01). With multivariate analysis, controlling for the possible confounding effects of education, parity, haemoglobin level at booking and malaria parasitaemia in peripheral blood, the difference in the incidence of anaemia in the two groups remained significant (p = 0.01; odds ratio = 0.5; 95% confidence interval = 0.29–0.85). Conclusion The IPT regime with sulphadoxine-pyrimethamine is an effective, practicable strategy to decrease risk of anaemia in women of low parity residing in areas endemic for malaria.Keywords
This publication has 17 references indexed in Scilit:
- Weekly chloroquine prophylaxis and the effect on maternal haemoglobin status at deliveryTropical Medicine & International Health, 2002
- The teratogenic risk of trimethoprim-sulfonamides: a population based case-control studyReproductive Toxicology, 2001
- Malaria prophylaxis and the reduction of anemia at childbirthInternational Journal of Gynecology & Obstetrics, 2001
- The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancyTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001
- Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight.The American Journal of Tropical Medicine and Hygiene, 2001
- Folic Acid Antagonists during Pregnancy and the Risk of Birth DefectsNew England Journal of Medicine, 2000
- Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997–1999Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trialThe Lancet, 1999
- Sickle cell trait, malaria and anaemia in pregnant Zambian womenTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983
- Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weightTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983